纳豆激酶抗血栓作用机制的实验研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:研究纳豆激酶抗血栓作用的机制。方法:以肾上腺素加冰浴制备大鼠急性血瘀模型,观察纳豆激酶对大鼠血液流变学的影响;分别采用ADP、凝血酶和花生四烯酸诱导大鼠血小板聚集,用比浊法测定不同时间点的聚集率及最大聚集率;采用Fluo-3/AM钙离子荧光指示剂,流式细胞仪测定纳豆激酶对凝血酶诱导的大鼠血小板胞浆游离钙离子浓度的影响;放免法测定血浆TXB2、6-Keto-PGF1α及ET-1的含量,硝酸还原酶法测定血浆NO含量,酶标法测定人血浆GMP-140和vWF的含量;通过Real Time PCR方法观察纳豆激酶对大鼠主动脉t-PA、PAI-1及UK基因表达的影响。
     结果:纳豆激酶能明显降低血瘀模型大鼠的全血低、中、高切粘度,血浆粘度,红细胞压积,纤维蛋白原,红细胞聚集指数及电泳指数;明显抑制ADP、凝血酶、花生四烯酸诱导的血小板聚集,其ED50分别为1431.9 IU/kg、1055.3 IU/kg和1390.8 IU/kg;纳豆激酶1000~2000IU/kg能显著抑制凝血酶诱导的血小板胞浆游离钙离子浓度的升高;降低血浆TXB2含量(P<0.05或P<0.01),升高6-Keto-PGF1α含量(P<0.05),使TXB2/6-Keto-PGF1α比值明显降低(P<0.05或P<0.01);降低血浆ET-1含量(P<0.05或P<0.01),增加NO含量(P<0.05或P<0.01),明显降低ET-1/NO比值(P<0.01);在体外,纳豆激酶40IU/mL~80IU/mL作用下能明显降低人血浆GMP-140和vWF含量(P<0.05或P<0.01);纳豆激酶1000~2000IU/kg可明显增加t-PA mRNA和UK mRNA的表达(P<0.05或P<0.01),但对PAI-1 mRNA的表达无明显性影响(P>0.05)。
     结论:纳豆激酶抗血栓作用机制可能与改善血液流变学,抑制血小板聚集,包括抑制血小板胞浆游离钙离子浓度,降低TXB2和ET-1含量,升高6-Keto-PGF1α和NO含量,降低GMP-140和vWF水平,以及通过促进t-PA和UK基因表达而提高机体的纤溶活性有关。
Objective: To study the antithrombotic mechanisms of nattokinase.
     Methods: A model of acute blood stasis was established by means of giving rats an injection of adrenalin and making it swim in ice-cold water, the change of hemorheology was observed after the rats took nattokinase for 10 days; Rat platelet aggregation induced by ADP,thrombin and arachidonic acid, was measured by turbidimetric method at different time. The cytosolic free calcium concentration [Ca2+]i in rat platelets was measured with Fluo-3/ AM and the flowcytometer. The levels of TXB2, 6-Keto-PGF1α, NO and ET-1 in rat plasma and the levels of GMP-140 and vWF in human plasma were measured. Expression of t-PA, UK and PAI-1 mRNA in rat aorta tissue was examined by Real Time PCR.
     Results: Nattokinase could markedly decrease the whole blood viscosity of low, middle, and high shear rate, plasma viscosity, hematocrit, fibrinogen, erythrocyte aggregation index and electrophoresis index. Nattokinase could significantly inhibit platelet aggregation induced by ADP,thrombin and arachidonic acid , and the values of ED50 (median effective dose) were 1431.9 IU/kg for ADP, 1055.3 IU/kg for thrombin and 1390.8 IU/kg for arachidonic acid, respectively. Nattokinase could decrease the [Ca2+]i in rat platelets induced by thrombin. The levels of 6-Keto-PGF1αand NO were increased, while the levels of TXB2 , ET-1, and the ratios of TXB2/6-Keto-PGF1αand ET-1/NO were reduced. And the levels of GMP-140 and vWF in human plasma were also decreased. Nattokinase could significantly increase the mRNA expression of t-PA and UK, but not influence the mRNA expression of PAI-1.
     Conclusion: Nattokinase had the effect of anti- thrombosis, and its mechanisms might be associated with the improvement of hemorheology in rats of acute blood stasis, inhibition of platelet aggregation, including the reductions of [Ca~(2+)]i in platelets, TXB2 and ET-1, increases of 6-Keto-PGF1αand NO, decreases of GMP-140 and vWF, and enhancement of fibrinolytic activity by promoting the gene expression of t-PA and UK.
引文
[ 1 ]Sagripanti A , Carpi A. Antithrombotic and prothrombotic activities of the vascular endothelium[ J ]. Biomed Pharmacother , 2000, 54 (2):107-11.
    [ 2 ]Rosenberg RD , Aird WC. Vascular-bed-specific hemostasis and Hypercoagulable states [ J ]. N Engl J Med , 1999 , 340 (20) :1555-64.
    [ 3 ]Repo H , Harlan JM. Mechanisms and consequences of phagocyte adhesion to endothelium [ J ]. Ann Med , 1999 , 31 (3) :156-65.
    [ 4 ]Cines DB , Pollak ES , Buck CA. Endothelial cells in physiology and in the pathophysiology of vascular disorders [ J ]. Blood , 1998 , 91 (10) :3527-61.
    [ 5 ]Gross PL , Aird WC. The endothelium and thrombosis [ J ]. Semin Thromb Hemost , 2000 , 26 (5) :463-78.
    [ 6 ]Brass L. Fifty (or more) ways to leave your platelets (in a thrombus) [ J ].Arterioscler Thromb Vasc Biol , 2004, 24(6):989-91.
    [ 7 ]Nieswandt B, Watson SP.Platelet-collagen interaction:is GPⅥ the central receptor[ J ]? BIood, 2003, 102: 449-61.
    [ 8 ]Zollner S , Aberle S , Harvey SE. Changes of endothelial nitric oxide synthase level and activity during endothelial cell proliferation[ J ]. Endothelium ,2000 ,7 (3): 169-84.
    [ 9 ] Raitakari OT , Celermajer DS. Testing for endothelial dysfunction[ J ].Ann Med , 2000 ,32 (5) :293-304.
    [10] 王鸿利.抗血栓药物的血液学原理[J].中国处方药,2004,1(22),58-63.
    [11] Chang CT , Fan MH , Kuo FC , et al. Potent fibrinolytic enzyme from a mutant of Bacillus subtilis IMR- NKI [ J ] . J Agric Food Chem , 2000 ,48 (8) : 3210-6.
    [12] Kirk P , Patterson RE , Lampe J . Development of a soy food frequency questionnaire to estimate isoflavone consumption in US adults[ J ] . J Am Diet Assoc , 1999 ,99 (5) : 558 - 63.
    [13] Urano T , Ihara H , Umemura K. The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis Cleaves and inactivates plasminogen activator inhibitor type 1[ J ] . J Biol Chem , 2001 , 276(27) : 24690-6.
    [14] Tanimoto H , Mori M , Motoki M , et al. Natto mucilage containing poly - gamma - glutamic acid increase soluble calcium in the rat small intestine [ J ] . Biosci Biotechnol Biochem , 2001 ,65 (3) : 516-21.
    [15] Yamaguchi M , Kakuda H , Gao YH , et al. Prolonged intake of fermented soybean ( natto) diets containing vitamin K2 (menaquinone-7) prevents bone loss in ovariectomized rats[ J ] . J Bone Miner Metab , 2000 , 18(2) : 71-6.
    [16] Tsukamoto Y, Kasai M , Kakuda H. Construction of a Bacillus subtilis (natto) with high productivity of vitamin K2 (menaquinone-7) by analog resistance [ J ] .Biosci Biotechnol Biochem , 2001 , 65 ( 9) : 2007-15.
    [17] Kaneki M , Hedges S J , Hosoi T , et al. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2 : possible implications for hip-fracture risk[ J ] . Nutrition , 2001 , 17(4) : 315 - 21.
    [18] 袁淑云.纳豆激酶粗提液对小鼠实验性高脂血症的降脂作用[J]. 现代医院,2005,15:10-2.
    [19] 段智变,江晓,江汉湖.纳豆粗提物抗兔高脂血症及抗氧化作用的研究[J]. 营养学报,2004,26:296-9.
    [20] 须见洋行.纳豆的机能性[J].日本酿造协会志,1990,85(8):518-24.
    [21] Takahashi C , Kikuchi N , Katou N. Possible anti-tumour-promoting activity of components in Japanese soybean fermented food , Natto: effect on gap junctional intercellular communication [ J ] . Carcinogenesis ,1995 ,16 (3) :471-6.
    [22] Easki H ,Hohara Y , Onozaki H ,et al .Antioxidative activity of natto[ J ]. Nippon Shokuhim Kogyo Gakkajshi ,1990 ,31(6):474-7.
    [23] Osawa R , Matsumoto K. Digestion of staphylococcal enterotoxin by Bacillus natto [ J ] . Antonie Van Leeuwenhoek , 1997 ,71 (4) :307-11.
    [24] Sumi H, Hamada H, Tsushima H, et al. A novel fibrinolytic enzyme ( nattoki-nase) inthe vegetable cheese natto, a typ ical and popular soybean food in the Japanese diet[J]. Experientia, 1987, 43 (10) : 1110-1.
    [25] Sumi H, Hamada H,Nakanishi K, et al. Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase [ J ]. Acta Haematol, 1990, 84(3): 139-43.
    [26] Kamata H, Yamagata Y, Nakamura T, et al. Characterization of the complex between α2macroglobulin and a serine proteinase from bacillus natto [ J ]. AgricBiol Chem, 1989, 53 (10) : 2695-702.
    [27] Fujita M, Hong K, Ito Y, et al. Transport of nattokinase across the rat intestinal tract[J]. Biol Pharm Bull , 1995,18(9):1194–6.
    [28] Fujita M , Nomura K , Hong K , et al . Purification and characterization of a strong fibrinolytic enzyme (nattokinase) in the vegetable cheese natto , a popular soybean fermented food in Japan [ J ] . Biochem Biophys Res. Commun , 1993 ,197 (3):1340-7.
    [29] Nakamura T, Youher Y, Eiji I. Nucleotide sequence of the Subtilisin NAT,aprN of Bacillus subtilis (natto) [ J ]. Biosci Biotech Biochem, 1992, 56 (11) :1869-72.
    [30] Sumi H. Single oral dose toxicity study of nattokinase(NSKFD) powder in rats[ J ] . apan Bio Science Laboratory , 1999 ,26 , February.
    [31] 胡景柱,夏寿华,吴林.纳豆冻干粉的安全性研究[J].安徽农业科学,2000,28(3):380-1.
    [32] 王俊菊,李培锋,关红.纳豆激酶抗凝血作用的研究[J].中国生化药物杂志,2004,25(5):276-8.
    [33] Akiomi Takano, Akira Hirata, Kazuya Ogasawara, et al. Effects and safety of subtilisin NAT (nattokinase) as a novel enzyme for pharmacological vitrectomy [J].Investigative Ophthalmology and Visual Science.2006,47,2075-79.
    [34] Suzuki Y, Kondo K, Ichise J, et al. Dietary supplementation with fermented soybeans suppresses intimal thickening[J]. Nutrition, 2003, 19: 261-4.
    [35] Suzuki Y, Kondo K, Matsumoto Y, et al. Dietary supplementation of fermented soybean, natto, suppresses intimal thickening and modulates the lysis of muralthrombi after endothelial injury in rat femoral artery [J]. Life Sci, 2003, 73(10): 1289-98.
    [36] 李欣志,刘建勋,尚晓泓. 重组纳豆激酶对Beagle犬和小型猪凝血和纤溶系统的不同影响[J].实验动物与比较医学,2006,26(1):16-8.
    [37] 李欣志,刘建勋,尚晓泓等. 重组纳豆激酶对小型猪冠状动脉血栓的溶解作用[J].中国药学杂志,2006,41(8):589-92.
    [38] Yoshikazu Yuki , Nakagawa T , Fujita M, et al . A Sandwich enzyme-linked immunosorbent asay for nattokinase[ J ]. Biosci Biotech Biochem, 1994 ,58(2) : 366-70.
    [39] Chavakis T ,Robin A , Pixley I , et al . A novel antithrombotic role for high molecular weight kininogen as inhibitor of plasminogen activator inhibitor-1 function [ J ]. J Biol Chem, 2002 , 277(36) :32677-82.
    [40] 徐红梅,刘青云,戴敏等.赤芍总苷对大鼠血液流变学的影响[J].2001,9(11):17-19.
    [41] 何小溪,徐华丽,于晓风等.人参Rb组皂苷对急性血瘀模型大鼠血小板聚集及血液流变学的影响[J].中国药理学通报,2007,23(9):1259-60.
    [42] 朱卫江,帕尔哈提·克里木,白杰等.草棉花总黄酮对大鼠血小板聚集及脑血栓形成的影响[J].新疆医科大学学报,2005,28(3):201-5.
    [43] 陈蓉, 谢梅林, 周佳.蛇床子素抑制血栓形成和血小板聚集的实验研究[J].2005,21(4):440-3.
    [44] 曾福仁,尹松梅.血小板胞浆游离钙与血栓性疾病[J].中华血液学杂志, 2002,23(9),501-2.
    [45] 庄明明,温奕欣,刘少列等.流式细胞仪测定血小板胞浆游离钙浓度[J].西安交通大学学报(医学版),2005,26(5),508-10.
    [46] 钟佩茹,林秀珍. 丹参注射液对正常大鼠血小板胞浆内游离钙浓度的影响[J].中国中西医结合外科杂志,2005 ,11(2),141-2.
    [47] Kyu-sil Choi , Sandra L , Fitzpatrick , et al . Regulation of plasmin dependent fibrin clot lysis by annexinⅡ heterotetramer [ J ]. J Biological Chemidtrg ,2001 , 276 (2) :25212-21.
    [48] Pais E , Alexy T , Holsworth RE Jr, et al. Effects of nattokinase, a profibrinoly -tic enzyme, on red blood cell aggregation and whole blood viscosity [ J ]. Clin Hemorheol Microcirc, 2006, 35(1-2):139–42.
    [49] Saeed SA , Rasheed H. Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation[ J ]. Acta Pharmacol Sin , 2003 ,24(1): 31-6.
    [50] Myers DD, Hawley AE, Farris DM, et al. P-selectin and leukocyte microparticles are associated with venous thrombogenesis[ J ]. J Vasc Surg, 2003, 38(5):1075-89.
    [51] Lip GY. Pearce LA,et al. Chin BS Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation. Heart. 2005, 91(6), 759-63.
    [52] 沈庆乐,张存琪,林闽溪等. 冠心病患者血栓前状态与血浆粘度变化的临床意义[J].福建医药杂志, 2000; 22(3):36-8.
    [53] Huber K. Plasminogen activator inhibitor type-1 ( part one ) : basic mechanisms, regulation , and role of thromboembolic disease[ J ]. J Thromb Thrombolysis, 2001 ,11 :183-93.
    [54] 杨林花,董春霞,王凤芝等. 组织型纤溶酶原激活剂及其抑制物的变化与冠心病的关系[J].血栓与止血学杂志,2004,10(1):28.
    [55] Kazuyuki S. Differential effects of enalapril and nitrendipine on thefibrinolytic system in essential hypertension [ J ] . Am Heart J , 2003 ,139 :1099-102.
    [ 1 ] Sumi H , Hamada H , Tsushima H , et al . A novel fibrinolytic enzyme (nattoki-nase) in the vegetable cheese natto: a typical and popular soybean food in the Japane- se diet [ J ] . Experientia , 1987 ,43(10):1110 - 1111.
    [ 2 ] Fujita M , Nomura K , Hong K , et al . Purification and characterization of a strong fibrinolytic enzyme (nattokinase) in the vegetable cheese natto , a popular soybean fermented food in Japan [ J ] . Biochem. Biophys .Res. Commun , 1993,197 (3):1340-1347.
    [ 3 ] P. Yong, H. Qing, Z. Ren-huai ,et al. Purification and characterization of a fibrinolytic enzyme produced by Bacillus amyloliquefaciens DC-4 screened from douchi, a traditional Chinese soybean food, Comp[J].Biochem Physiol. 2003, 134, 45–134, 52.
    [ 4 ] Zhong-Liang Zheng, Mao-Qing Ye, Zhen-Yu Zuo, et al. Probing the importance of hydrogen bonds in the active site of the subtilisin nattokinase by site-directed mutagenesis and molecular dynamics simulation[J]. Biochem. J, 2006,395, 509-515.
    [ 5 ] Shuming Wu, Chi Feng , Jin Zhong , et al. Roles of S3 Site Residues of Nattokinase on its Activity and Substrate Specificity [ J ]. Journal of Biochemistry, 2007, 142(3): 357–364 .
    [ 6 ] Sumi H, Hamada H , Nakanishi K , et al .Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase [ J ].Acta Haematol, 1990, 84(3): 139 -143.
    [ 7 ] Akiomi Takano, Akira Hirata, Kazuya Ogasawara, et al. Effects and safety of subtilisin NAT (nattokinase) as a novel enzyme for pharmacological vitrectomy [ J ]. Investigative Ophthalmology and Visual Science, 2006, 47, 2075-2079.
    [ 8 ] Suzuki Y, Kondo K, Matsumoto Y , et al. Dietary supplementation of fermented soybean, natto, suppresses intimal thickening and modulates the lysis of mural thrombi after endothelial injury in rat femoral artery [J]. Life Sci, 2003, 73(10): 1289-1298.
    [ 9 ] Saiura A, Sata M, Hirata Y,et al. Circulating smooth muscle progenitor cells contribute to atherosclerosis[J]. Nature Medcine, 2001,7:382–383.
    [10] Kaida T, Matsuno H, Niwa M, et al. Antiplatelet effect of FK633, a platelet glycoprotein IIb/IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery. Thromb Haemost ,1997,77(3): 562-567.
    [11] Cesarone MR, Belcaro G, Nicolaides A, et al. Prevention of venous thrombosis in long-haul flights with Flite Tabs: the LONFLIT-FLITE randomized, controlled trial [ J ]. Angiology, 2003, 54(5):531-539.
    [12] Yamashita T, Oda E, Giddings JC, et al..The effect of dietary bacillus natto productive protein on in vivo endogenous thrombolysis[ J ]. Pathophysiology of Haemostasis & Thrombosis. 2003, 33(3), 138-143.
    [13] Pais E , Alexy T , Holsworth RE Jr, et al. Effects of nattokinase, a profibrinolytic enzyme, on red blood cell aggregation and whole blood viscosity [ J ]. Clinical Hemorheology and Microcirculation , 2006, 35(1-2):139–142.
    [14] Suzuki Y, Kondo K, Ichise J, et al. Dietary supplementation with fermented soybeans suppresses intimal thickening [ J ]. Nutrition, 2003, 19(3):261-264.
    [15]郭婷,姚文兵,高向东. 纳豆激酶的纤溶活性及其机理研究[J].中国生化药物杂志,2004,25(4),226-228.
    [16] Yoshikazu Yuki , Nakagawa T , Fujita M, et al . A Sandwich enzyme-linked immunosorbent asay for nattokinase[ J ]. Biosci Biotech Biochem, 1994 ,58(2) : 366-70.
    [17] Kyu-sil Choi , Sandra L , Fitzpatrick , et al . Regulation of plasmin dependent fibrin clot lysis by annexin Ⅱ hetero-tetramer[ J ]. J of Biological Chemidtrg , 2001 , 276 (2) :25212~25221. [18 ] Chavakis T ,Robin A , Pixley I , et al . A novel antithronbotic role for high molecular weight kininogen as inhibitor of plasminogen activator inhibitor function [ J ]. J Biol Chem, 2002 ,277(36) :32677~32682. [19 ] Urono T , Hayato I , Kazuo U , et al . The profibrinolytic enzyme subtilisin NATpurified from bacillus subtilis cleaves and inactivates plasminogen activator inhibitor type-1[ J ]. J Biol Chem , 2001 ,276 (27) :24690-24696.
    [20] Fujita M, Hong K, Ito Y, et al.Transport of nattokinase across the rat intestinal tract[J]. Biol Pharm Bull , 1995,18(9):1194–1196.
    [21] Sumi H. Single oral dose toxicity study of nattokinase(NSKFD) powder in rats[J ] . Japan Bio Science Laboratory ,1999 ,26 ,February.
    [22] 胡景柱,夏寿华,吴林.纳豆冻干粉的安全性研究[J].安徽农业科学,2000,28(3):380–381.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700